Postoperative radiotherapy of intermediate-risk head and neck cancer in 134 patients: Does subset matter?

被引：1
|
作者：
Ampil, Federico L. [1 ]
Caldito, Gloria [2 ]
Nathan, Cherie-Ann [3 ]
Vora, Moiz [4 ]
Richards, Troy [1 ]
机构：
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Radiol, Shreveport, LA 71105 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA
[3] Louisiana State Univ, Hlth Sci Ctr, Dept Otolaryngol Head & Neck Surg, Shreveport, LA 71105 USA
[4] Loyola Univ Med Ctr, Dept Pathol, Chicago, IL USA
来源：
CLINICAL OTOLARYNGOLOGY | 2019年 / 44卷 / 02期
关键词：
SQUAMOUS-CELL CARCINOMA; RECURRENCE; OUTCOMES; SURGERY;
D O I：
10.1111/coa.13244
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页码：176 / 178
页数：3
相关论文
共 50 条
  • [1] Long-term survival in patients with intermediate-risk head and neck cancer treated with adjuvant radiotherapy
    Ampil, Federico L.
    Nathan, Cherie-Ann
    Asarkar, Ameya
    ORAL ONCOLOGY, 2021, 114
  • [2] Survival Benefit of Postoperative Chemotherapy for Intermediate-Risk Advanced Stage Head and Neck Cancer
    Chen, M. M.
    Colevas, A. D.
    Megwalu, U.
    Divi, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1326 - 1326
  • [3] Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer
    Selzer, Edgar
    Grah, Anja
    Heiduschka, Gregor
    Kornek, Gabriela
    Thurnher, Dietmar
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (06) : 486 - 494
  • [4] Delay of postoperative radiotherapy in head and neck cancer patients
    Blot, E
    Astruc, E
    Bastit, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1342 - 1342
  • [5] Stratifying intermediate-risk patients for radiotherapy
    Mark K. Buyyounouski
    Nature Reviews Urology, 2013, 10 : 438 - 439
  • [6] Stratifying intermediate-risk patients for radiotherapy
    Buyyounouski, Mark K.
    NATURE REVIEWS UROLOGY, 2013, 10 (08) : 438 - 439
  • [7] Nivolumab Adjuvant in Combination with Postoperative Radiotherapy and as Maintenance in Patients with Intermediate Risk Locally Advanced Head and Neck Cancer - The NadiHN Trial
    Bauernfeind, Franz-Georg
    Schaefer, Henning
    Hautmann, Matthias
    Gauler, Thomas
    Mahlberg, Rolf
    Budach, Wilfried
    Tarnaskovics, Balint
    Baumann, Rene
    Eble, Michael
    Hasenkamp, Justin
    Koppelle, Adriane
    Reinacher-Schick, Anke
    Pigorsch, Steffi
    Lammert, Anne
    Meffert, Lisa
    Grosu, Anca-Ligia
    Hadizadeh, Dariusch
    Kristiansen, Glen
    Heimann, Martina
    Dietz, Andreas
    Brossart, Peter
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 95 - 95
  • [8] Radiotherapy in low and intermediate-risk prostate cancer
    Yalman, Deniz
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 86 - 91
  • [9] RADIOTHERAPY FOR POSTOPERATIVE PERSISTENT CANCER OF HEAD AND NECK
    HOOVER, SV
    MOSS, WT
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1974, 7 (01) : 175 - 192
  • [10] IMMUNOSUPPRESSION FOLLOWING POSTOPERATIVE RADIOTHERAPY IN PATIENTS WITH HEAD AND NECK-CANCER
    MAIER, H
    DANIEL, V
    HEIMLICH, F
    FRANK, C
    OPELZ, G
    HNO, 1995, 43 (06) : 364 - 370
12345